THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

ZAZOVE ASSOCIATES LLC's Holding History (CIK: 0001009012)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 580,000 Value ($000) $539 Avg Close — Range —
Q1 2022
Shares 1,250,000 Value ($000) $1,194 Avg Close — Range —
Q3 2021
Shares 1,250,000 Value ($000) $1,163 Avg Close — Range —
Q2 2021
Shares 3,182,000 Value ($000) $3,031 Avg Close — Range —
Q1 2021
Shares 3,182,000 Value ($000) $3,246 Avg Close — Range —
Q4 2020
Shares 3,773,000 Value ($000) $3,584 Avg Close — Range —
Q3 2020
Shares 3,773,000 Value ($000) $3,367 Avg Close — Range —
Q2 2020
Shares 5,923,000 Value ($000) $5,790 Avg Close — Range —
Q1 2020
Shares 7,273,000 Value ($000) $7,237 Avg Close — Range —
Q4 2019
Shares 16,985,000 Value ($000) $17,664 Avg Close — Range —
Q3 2019
Shares 19,065,000 Value ($000) $17,683 Avg Close — Range —
Q2 2019
Shares 18,530,000 Value ($000) $16,075 Avg Close — Range —
Q1 2019
Shares 19,230,000 Value ($000) $18,725 Avg Close — Range —
Q4 2018
Shares 18,010,000 Value ($000) $18,539 Avg Close — Range —
Q3 2018
Shares 17,895,000 Value ($000) $21,161 Avg Close — Range —
Q2 2018
Shares 17,895,000 Value ($000) $17,627 Avg Close — Range —
Q1 2018
Shares 18,937,000 Value ($000) $19,221 Avg Close — Range —
Q4 2017
Shares 16,505,000 Value ($000) $18,114 Avg Close — Range —
Q3 2017
Shares 8,170,000 Value ($000) $10,024 Avg Close — Range —